Skip to main content

Advertisement

SpringerLink
Log in

Myelodysplastic following treatment of chronic lymphocytic leukemia (CLL) with 2-chlorodeoxyadenosine (2-CdA)

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Authors
  1. SH Kroft
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. MS Tallman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. JM Shaw
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M Thangavelu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. LA Peterson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kroft, S., Tallman, M., Shaw, J. et al. Myelodysplastic following treatment of chronic lymphocytic leukemia (CLL) with 2-chlorodeoxyadenosine (2-CdA). Leukemia 11, 170 (1997). https://doi.org/10.1038/sj.leu.2400523

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2400523

  • Springer Nature Limited

This article is cited by

Search

Navigation